Quest Diagnostics (DGX) | Stock Overview & Key Data
Quest Diagnostics Performance Comparison
Stock Range
Today's Range
Low: $179.93
High: $185.62
on August 22, 2025
52 Week Range
Low: $146.17
High: $185.62
on October 7, 2024
on August 22, 2025
All-Time High: $185.70 on August 22, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$20.1B
EPS
8.34
P/E Ratio (TTM)
21.56
Forward P/E
18.42
P/B Ratio
2.79
PEG Ratio
0.96
Div. Yield
N/A
ROE
14.26%
Beta
0.459
Debt to Equity
86.90
Financial Highlights
Profitability
Gross Margin
34.15%
Operating Margin
15.10%
Profit Margin
9.03%
Returns and Earnings
Return on Assets (TTM)
6.34%
Return on Equity (TTM)
14.26%
EBITDA
$2.1B
Net Income (TTM)
$945.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$95.12
Quarterly Revenue Growth (YoY)
15.20%
Quarterly Earnings Growth (YoY)
23.10%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics DGX | 20.10B Large-cap | 2.96% | 10.38% | 7.77% | 6.67% | 21.70% | 19.64% | 44.55% | 65.89% |
| Thermo Fisher TMO | 184.10B Large-cap | -0.26% | 19.46% | 21.46% | -9.16% | -7.43% | -20.19% | -14.18% | 13.97% |
| Danaher DHR | 151.04B Large-cap | -3.01% | 8.42% | 9.15% | -3.01% | -11.27% | -24.34% | -17.95% | 11.85% |
| Idexx Laboratories IDXX | 50.94B Large-cap | -3.20% | 21.54% | 26.39% | 39.82% | 54.84% | 29.69% | 80.92% | 64.87% |
| Agilent Technologies A | 33.94B Large-cap | -1.45% | 4.56% | 7.57% | -13.46% | -12.20% | -16.84% | -9.79% | 17.27% |
| Iqvia Holdings IQV | 32.73B Large-cap | -2.12% | 16.63% | 35.04% | -2.96% | -4.99% | -25.53% | -15.61% | 14.99% |
Ownership & Short Interest
Insider Ownership
0.40%
Institutional Ownership
99.65%
Shares Short
5M
Short Ratio
3.60
Short % of Shares Outstanding
4.84%
Average 10-Day Volume
788K
Average 90-Day Volume
1M
Quest Diagnostics Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Quest Diagnostics would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is DGX's 52-week high and low?
- In the last 52 weeks, Quest Diagnostics reached a high of $185.62 (on August 22, 2025) and a low of $146.17 (on October 7, 2024).
- What is the market cap and P/E ratio for DGX?
- Curious about Quest Diagnostics's size and valuation? Its market capitalization stands at 20.10B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.56, and the forward P/E (looking ahead) is 18.42.
- Does DGX pay dividends? If so, what's the yield?
- As for dividends, Quest Diagnostics isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Quest Diagnostics's main competitors or similar companies to consider before investing?
When looking at Quest Diagnostics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.10B Healthcare Diagnostics & Research -20.19% -14.18% Danaher
DHR151.04B Healthcare Diagnostics & Research -24.34% -17.95% Idexx Laboratories
IDXX50.94B Healthcare Diagnostics & Research 29.69% 80.92% Agilent Technologies
A33.94B Healthcare Diagnostics & Research -16.84% -9.79% Iqvia Holdings
IQV32.73B Healthcare Diagnostics & Research -25.53% -15.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Quest Diagnostics Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Quest Diagnostics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.26%, the Debt to Equity ratio from the most recent quarter is 86.90, and its Gross Profit Margin stands at 34.15%.
- What is the recent revenue and earnings growth for DGX?
- Looking at Quest Diagnostics's growth, its revenue over the trailing twelve months (TTM) was $11B. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.20%, and quarterly earnings saw a YoY growth of 23.10%.
- How much of DGX stock is held by insiders and institutions?
- Wondering who owns Quest Diagnostics stock? Company insiders (like executives and directors) hold about 0.40% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 99.65%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.